Skip to content

CalAmp CAMP Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Rapport Therapeutics, Inc. logo
Rapport Therapeutics, Inc.RAPP
-$3.49M-1,155%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-$9.9M-176%
Polaryx Therapeutics, Inc.
 logo
Polaryx Therapeutics, Inc. PLYX
-$16.5K
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
-$60.03M-290%
Scholar Rock logo
Scholar RockSRRK
$4.68M+237%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-$6.67M+43.8%

Other financials

Income statement

See full
Revenue$1.3M+50.8%
Operating income-$13.1M+0.2%
Net income-$18.3M-47.4%
EPS (diluted)-$0.32+48.4%

Balance sheet

See full
Cash & equivalents$100.8M+97.9%
Total debt$2.1M-73.2%
Total equity$30.9M-40.1%
Total assets$105.5M+68.0%

Cash flow

See full
Operating cash flow-$11.0M+23.1%
CapEx--100%
Free cash flow-$11.0M+24.6%

Valuation

See full
Market cap$226.92M+666%
Enterprise value$128.2M-3,860%
P/S57.7×+47.8×

Profitability

See full
Operating margin-1,335.2%-512pp
Net margin-2,193.7%-581pp
FCF margin-1,254%

Returns & leverage

See full
Return on equity-209.3%
Debt / equity0.1×-0.1×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by CalAmp in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CalAmp's change in accrued liabilities?
CalAmp (CAMP) reported change in accrued liabilities of -$1.37M in Q1 2026.
How has CalAmp's change in accrued liabilities changed year-over-year?
CalAmp's change in accrued liabilities increased by 50.9% year-over-year, from -$2.79M to -$1.37M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.